Suppression of CX43 expression by miR-20a in the progression of human prostate cancer

References

• Buchan JR, Parker R. Molecular biology. The two faces of miRNA. Science 2007; 318:1877 - 8; http://dx.doi.org/10.1126/science.1152623; PMID: 18096794
   PubMed Web of Science ®Google Scholar
• Foshay KM, Gallicano GI. miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation. Dev Biol 2009; 326:431 - 43; http://dx.doi.org/10.1016/j.ydbio.2008.11.016; PMID: 19073166
   PubMed Web of Science ®Google Scholar
• Mizuno Y, Yagi K, Tokuzawa Y, Kanesaki-Yatsuka Y, Suda T, Katagiri T, et al. miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. Biochem Biophys Res Commun 2008; 368:267 - 72; http://dx.doi.org/10.1016/j.bbrc.2008.01.073; PMID: 18230348
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69 - 90; http://dx.doi.org/10.3322/caac.20107; PMID: 21296855
   PubMed Web of Science ®Google Scholar
• Crawford ED, Eisenberger MA, McLeod DG, Spaulding JT, Benson R, Dorr FA, et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 1989; 321:419 - 24; http://dx.doi.org/10.1056/NEJM198908173210702; PMID: 2503724
   PubMed Web of Science ®Google Scholar
• Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, et al, TAX 327 Investigators. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004; 351:1502 - 12; http://dx.doi.org/10.1056/NEJMoa040720; PMID: 15470213
   PubMed Web of Science ®Google Scholar
• Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, et al. Cumulative cost pattern comparison of prostate cancer treatments. Cancer 2007; 109:518 - 27; http://dx.doi.org/10.1002/cncr.22433; PMID: 17186528
   PubMed Web of Science ®Google Scholar
• Hudson RS, Yi M, Esposito D, Watkins SK, Hurwitz AA, Yfantis HG, et al. MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res 2012; 40:3689 - 703; http://dx.doi.org/10.1093/nar/gkr1222; PMID: 22210864
   PubMed Web of Science ®Google Scholar
• Shi GH, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, et al. Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells. Acta Pharmacol Sin 2010; 31:867 - 73; http://dx.doi.org/10.1038/aps.2010.48; PMID: 20581857
   PubMed Web of Science ®Google Scholar
• Leite KR, Tomiyama A, Reis ST, Sousa-Canavez JM, Sañudo A, Dall’Oglio MF, et al. MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer. J Urol 2011; 185:1118 - 22; http://dx.doi.org/10.1016/j.juro.2010.10.035; PMID: 21255804
   PubMed Web of Science ®Google Scholar
• Majid S, Dar AA, Saini S, Yamamura S, Hirata H, Tanaka Y, et al. MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer 2010; 116:5637 - 49; http://dx.doi.org/10.1002/cncr.25488; PMID: 20737563
   PubMed Web of Science ®Google Scholar
• Sun T, Wang Q, Balk S, Brown M, Lee GS, Kantoff P. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res 2009; 69:3356 - 63; http://dx.doi.org/10.1158/0008-5472.CAN-08-4112; PMID: 19351832
   PubMed Web of Science ®Google Scholar
• Loewenstein WR, Rose B. The cell-cell channel in the control of growth. Semin Cell Biol 1992; 3:59 - 79; http://dx.doi.org/10.1016/S1043-4682(10)80008-X; PMID: 1623203
   PubMedGoogle Scholar
• Trosko JE, Chang CC, Wilson MR, Upham B, Hayashi T, Wade M. Gap junctions and the regulation of cellular functions of stem cells during development and differentiation. Methods 2000; 20:245 - 64; http://dx.doi.org/10.1006/meth.1999.0941; PMID: 10671317
   PubMed Web of Science ®Google Scholar
• Tang B, Peng ZH, Yu PW, Yu G, Qian F. Expression and significance of Cx43 and E-cadherin in gastric cancer and metastatic lymph nodes. Med Oncol 2011; 28:502 - 8; http://dx.doi.org/10.1007/s12032-010-9492-5; PMID: 20373058
   PubMed Web of Science ®Google Scholar
• Xu CX, Jia Y, Yang WB, Wang F, Shen SR. [Relationship between Helicobacter pylori infection and expression of connexin (Cx) 32 and Cx43 genes in gastric cancer and gastric precancerous lesions]. Zhonghua Yi Xue Za Zhi 2008; 88:1523 - 7; PMID: 18956631
   PubMedGoogle Scholar
• Li J, Cheng L, Wang LJ, Liu HC, Li L, Wang XL, et al. Cell surface sialic acid inhibits Cx43 gap junction functions in constructed Hela cancer cells involving in sialylated N-cadherin. Mol Cell Biochem 2010; 344:241 - 51; http://dx.doi.org/10.1007/s11010-010-0548-9; PMID: 20803237
   PubMed Web of Science ®Google Scholar
• Kanczuga-Koda L, Koda M, Sulkowski S, Wincewicz A, Zalewski B, Sulkowska M. Gradual loss of functional gap junction within progression of colorectal cancer -- a shift from membranous CX32 and CX43 expression to cytoplasmic pattern during colorectal carcinogenesis. In Vivo 2010; 24:101 - 7; PMID: 20133984
   PubMed Web of Science ®Google Scholar
• Lamiche C, Clarhaut J, Strale PO, Crespin S, Pedretti N, Bernard FX, et al. The gap junction protein Cx43 is involved in the bone-targeted metastatic behaviour of human prostate cancer cells. Clin Exp Metastasis 2012; 29:111 - 22; http://dx.doi.org/10.1007/s10585-011-9434-4; PMID: 22080401
   PubMed Web of Science ®Google Scholar
• Hernandez M, Shao Q, Yang XJ, Luh SP, Kandouz M, Batist G, et al. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells. Prostate 2006; 66:1151 - 61; http://dx.doi.org/10.1002/pros.20451; PMID: 16652385
   PubMed Web of Science ®Google Scholar
• Shao Q, Wang H, McLachlan E, Veitch GI, Laird DW. Down-regulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. Cancer Res 2005; 65:2705 - 11; http://dx.doi.org/10.1158/0008-5472.CAN-04-2367; PMID: 15805269
   PubMed Web of Science ®Google Scholar
• Hirschi KK, Xu CE, Tsukamoto T, Sager R. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ 1996; 7:861 - 70; PMID: 8809403
   PubMedGoogle Scholar
• Hagman Z, Larne O, Edsjö A, Bjartell A, Ehrnström RA, Ulmert D, et al. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions. Int J Cancer 2010; 127:2768 - 76; http://dx.doi.org/10.1002/ijc.25269; PMID: 21351256
   PubMed Web of Science ®Google Scholar
• Bhatnagar N, Li X, Padi SK, Zhang Q, Tang MS, Guo B. Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. Cell Death Dis 2010; 1:e105; http://dx.doi.org/10.1038/cddis.2010.85; PMID: 21368878
   PubMed Web of Science ®Google Scholar
• Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, et al. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun 2008; 377:114 - 9; http://dx.doi.org/10.1016/j.bbrc.2008.09.086; PMID: 18834855
   PubMed Web of Science ®Google Scholar
• Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 2008; 14:1271 - 7; http://dx.doi.org/10.1038/nm.1880; PMID: 18931683
   PubMed Web of Science ®Google Scholar
• Folini M, Gandellini P, Longoni N, Profumo V, Callari M, Pennati M, et al. miR-21: an oncomir on strike in prostate cancer. Mol Cancer 2010; 9:12; http://dx.doi.org/10.1186/1476-4598-9-12; PMID: 20092645
   PubMed Web of Science ®Google Scholar
• Leite KR, Sousa-Canavez JM, Reis ST, Tomiyama AH, Camara-Lopes LH, Sañudo A, et al. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Urol Oncol 2011; 29:265 - 9; http://dx.doi.org/10.1016/j.urolonc.2009.02.002; PMID: 19372056
   PubMed Web of Science ®Google Scholar
• Fan X, Liu Y, Jiang J, Ma Z, Wu H, Liu T, et al. miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells. Acta Biochim Biophys Sin (Shanghai) 2010; 42:318 - 24; http://dx.doi.org/10.1093/abbs/gmq026; PMID: 20458444
   PubMed Web of Science ®Google Scholar
• Pesta M, Klecka J, Kulda V, Topolcan O, Hora M, Eret V, et al. Importance of miR-20a expression in prostate cancer tissue. Anticancer Res 2010; 30:3579 - 83; PMID: 20944140
   PubMed Web of Science ®Google Scholar
• Huang G, Nishimoto K, Zhou Z, Hughes D, Kleinerman ES. miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res 2012; 72:908 - 16; http://dx.doi.org/10.1158/0008-5472.CAN-11-1460; PMID: 22186140
   PubMed Web of Science ®Google Scholar
• Chai H, Liu M, Tian R, Li X, Tang H. miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines. Acta Biochim Biophys Sin (Shanghai) 2011; 43:217 - 25; http://dx.doi.org/10.1093/abbs/gmq125; PMID: 21242194
   PubMed Web of Science ®Google Scholar
• Yu Z, Wang C, Wang M, Li Z, Casimiro MC, Liu M, et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol 2008; 182:509 - 17; http://dx.doi.org/10.1083/jcb.200801079; PMID: 18695042
   PubMed Web of Science ®Google Scholar
• Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006; 103:2257 - 61; http://dx.doi.org/10.1073/pnas.0510565103; PMID: 16461460
   PubMed Web of Science ®Google Scholar
• Hirschi KK, Burt JM, Hirschi KD, Dai C. Gap junction communication mediates transforming growth factor-beta activation and endothelial-induced mural cell differentiation. Circ Res 2003; 93:429 - 37; http://dx.doi.org/10.1161/01.RES.0000091259.84556.D5; PMID: 12919949
   PubMed Web of Science ®Google Scholar
• Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, Boynton AL. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res 1998; 58:5089 - 96; PMID: 9823317
   PubMed Web of Science ®Google Scholar
• Benko G, Spajić B, Demirović A, Stimac G, Kru Sbreve Lin B, Tomas D. Prognostic value of connexin43 expression in patients with clinically localized prostate cancer. Prostate Cancer Prostatic Dis 2011; 14:90 - 5; http://dx.doi.org/10.1038/pcan.2010.51; PMID: 21173791
   PubMed Web of Science ®Google Scholar